CS-Keys

About:

CS-Keys is a biotechnology company discovers and develops cancer-associated biomarkers using proteomics.

Top Investors: BioCrossroads, Prolog Ventures, CHV Capital, Triathlon Medical Venture Partners, Ceres Venture Fund

Description:

CS-Keys is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer.

Total Funding Amount:

$6.54M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)cs-keys.com

Founders:

Claire Deselle, Derek J. Hoelz, Lauren Schnaper, Linda H Malkas, Robert J. Hickey

Number of Employees:

1-10

Last Funding Date:

2008-01-25

IPO Status:

Private

Industries: